These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6397983)

  • 1. Captopril enhances in vitro human lymphocyte thymidine incorporation.
    Simon MR; Weinstock JV; Morrell RM; Roi LD; Howard LM
    Agents Actions; 1984 Dec; 15(5-6):525-8. PubMed ID: 6397983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril(SQ 14,225): in vitro and in vivo influence on the proliferative response of rat lymphocytes.
    Binderup L; Bramm E; Arrigoni-Martelli E
    Experientia; 1982 Mar; 38(3):399-401. PubMed ID: 7042381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the granulomatous response in murine schistosomiasis by the chronic administration of captopril, an inhibitor of angiotensin-converting enzyme.
    Weinstock JV; Boros DL
    Gastroenterology; 1981 Nov; 81(5):953-8. PubMed ID: 6269948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of concanavalin A, phytohemagglutinin, pokeweed mitogen, and lipopolysaccharide on the replication and immunoglobulin synthesis by canine peripheral blood lymphocytes in vitro.
    Letwin BW; Quimby FW
    Immunol Lett; 1987 Jan; 14(2):79-85. PubMed ID: 3583319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of converting enzyme inhibition with captopril on in vitro angiotensin production in sheep.
    Fei DT; Coghlan JP; Scoggins BA
    Clin Exp Pharmacol Physiol; 1981; 8(5):447-50. PubMed ID: 6276058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of angiotensin II on human mononuclear cell reactivity: suppression of PHA-P-induced thymidine incorporation.
    Simon MR; Engel DE; Weinstock JV; Roi LD
    Immunol Invest; 1985 Oct; 14(5):389-400. PubMed ID: 4077153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat.
    Evered MD; Robinson MM
    J Physiol; 1984 Mar; 348():573-88. PubMed ID: 6325675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats.
    Unger T; Hübner D; Schüll B; Yukimura T; Rascher W; Lang RE; Ganten D
    Am J Cardiol; 1982 Apr; 49(6):1530-2. PubMed ID: 6280482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrageenan-mediated suppression or augmentation of mitogen-induced lymphocyte proliferation.
    Neveu PJ; Perdoux D
    Int J Immunopharmacol; 1984; 6(3):187-91. PubMed ID: 6746172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of angiotensin I-converting enzyme in rat lung with captopril: the effect of adrenalectomy.
    Fyhrquist F; Grönhagen-Riska C; Forslund T; Tikkanen I
    Am J Cardiol; 1982 Apr; 49(6):1508-10. PubMed ID: 6280480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclophosphamide on in vitro human lymphocyte culture and mitogenic stimulation.
    Sharma BS
    Transplantation; 1983 Feb; 35(2):165-8. PubMed ID: 6600859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The measurement of lymphocyte size and thymidine uptake in comparative response to mitogen stimulation in vitro.
    Hause LL; Becker M
    Am J Clin Pathol; 1982 Apr; 77(4):414-9. PubMed ID: 7041619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of in vitro administration of captopril on vascular reactivity of rat aorta.
    Kikta DC; Fregly MJ
    Hypertension; 1982; 4(1):118-24. PubMed ID: 7037633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II inhibition of mitogen- and antigen-induced human blood mononuclear cell thymidine uptake.
    Simon MR; Weinstock JV
    J Clin Lab Immunol; 1985 Nov; 18(3):141-4. PubMed ID: 4087284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of captopril on rat aortic angiotensin-converting enzyme.
    Velletri P; Bean BL
    J Cardiovasc Pharmacol; 1982; 4(2):315-25. PubMed ID: 6175817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
    Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D
    Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML; Kurz KD
    J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
    [No Abstract]   [Full Text] [Related]  

  • 19. Captopril decreases vascular reactivity independently of changes in converting enzyme activity and prostaglandin release in the rat isolated kidney.
    Chiba S; Quilley CP; Quilley J; McGiff JC
    Eur J Pharmacol; 1982 Sep; 83(3-4):243-52. PubMed ID: 6293842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of converting enzyme inhibitor captopril on T cell functions in essential hypertension.
    Shasha SM; Nusam D; Labin L; Kristal B; Steinberger O; Barzilai M; Makov EU; Shkolnik T
    Nephron; 1991; 59(4):586-90. PubMed ID: 1766497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.